Publications in collaboration with researchers from Hospital de Galdakao - Usansolo (16)

2025

  1. Final 5-year outcomes of the Epic02 – RANGO study: A real-world registry of the durable fluoroacrylate polymer-based sirolimus-eluting Angiolite® stent

    Cardiovascular Revascularization Medicine

2024

  1. Clinical profile and outcomes in very elderly patients with atrial fibrillation anticoagulated with rivaroxaban: data from the EMIR study

    Journal of Geriatric Cardiology, Vol. 21, Núm. 7, pp. 723-732

2023

  1. Very long-term efficacy and safety of paclitaxel-eluting balloon after a bare-metal stent for the treatment of ST-elevation myocardial infarction: 8-year results of a randomized clinical trial (PEBSI study)

    Cardiovascular Diagnosis and Therapy, Vol. 13, Núm. 5

2022

  1. Use of rivaroxaban attenuates renal function impairment in patients with atrial fibrillation: insights of the EMIR study

    European Journal of Clinical Investigation

  2. Variables affecting the quality of anticoagulation in atrial fibrillation patients newly initiating vitamin K antagonists: insights from the national and multicentre SULTAN registry

    Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology, Vol. 24, Núm. 1, pp. 4-11

2021

  1. Antithrombotic strategies in elderly patients with atrial fibrillation revascularized with drug-eluting stents: PACO-PCI (EPIC-15) registry

    International Journal of Cardiology, Vol. 338, pp. 63-71

  2. Consequences of canceling elective invasive cardiac procedures during Covid-19 outbreak

    Catheterization and Cardiovascular Interventions, Vol. 97, Núm. 5, pp. 927-937

  3. Impact of diabetes in patients waiting for invasive cardiac procedures during COVID-19 pandemic

    Cardiovascular Diabetology, Vol. 20, Núm. 1

  4. Real-world registry of the durable Angiolite fluoroacrylate polymer-based sirolimus-eluting stent: The EPIC02 – RANGO study

    REC: Interventional Cardiology, Vol. 3, Núm. 4, pp. 258-266

2020

  1. Impact of COVID-19 on ST-segment elevation myocardial infarction care. The Spanish experience

    Revista Espanola de Cardiologia, Vol. 73, Núm. 12, pp. 994-1002

2019

  1. Atrial Fibrillation in Active Cancer Patients: Expert Position Paper and Recommendations

    Revista Espanola de Cardiologia, Vol. 72, Núm. 9, pp. 749-759

  2. Cardiologists and the Cardiology of the Future. Vision and Proposals of the Spanish Society of Cardiology for the Cardiology of the 21st Century

    Revista Espanola de Cardiologia, Vol. 72, Núm. 8, pp. 649-657

2018

  1. Angina and Ischemia at 2 Years With Bioresorbable Vascular Scaffolds and Metallic Drug-eluting Stents. ESTROFA Ischemia BVS-mDES Study

    Revista Espanola de Cardiologia, Vol. 71, Núm. 5, pp. 327-334

2015

  1. Immediate and Long-Term Results of Drug-Eluting Stents in Mammary Artery Grafts

    American Journal of Cardiology, Vol. 116, Núm. 11, pp. 1695-1699

2012

  1. Double antiplatelet therapy after drug-eluting stent implantation: Risk associated with discontinuation within the first year

    Journal of the American College of Cardiology, Vol. 60, Núm. 15, pp. 1333-1339

2008

  1. Drug-Eluting Stent Thrombosis. Results From the Multicenter Spanish Registry ESTROFA (Estudio ESpañol sobre TROmbosis de stents FArmacoactivos)

    Journal of the American College of Cardiology, Vol. 51, Núm. 10, pp. 986-990